---
title: "Pharscin Pharma: Injectable Sulbactam-Nafcillin has received drug re-registration approval"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263234216.md"
description: "Pharscin Pharma announced that it recently received the \"Drug Re-registration Approval Notice\" for its product, injectable sulbactam-natamycin, issued by the Chongqing Municipal Drug Administration. The drug approval number is valid until October 22, 2030. The re-registration of this product is approved. Since this product has not been produced for a long time, before resuming production, the holder must complete the relevant work according to the requirements of related documents and submit a resumption application to the Municipal Drug Administration. After on-site inspection and passing the quality check of a batch of products, and subsequent two batches of products passing inspection, it can be marketed for sale"
datetime: "2025-10-29T08:06:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263234216.md)
  - [en](https://longbridge.com/en/news/263234216.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263234216.md)
---

# Pharscin Pharma: Injectable Sulbactam-Nafcillin has received drug re-registration approval

Pharscin Pharma announced that it recently received the "Drug Re-registration Approval Notice" for its product, injectable sulbactam-natamycin, issued by the Chongqing Municipal Drug Administration. The drug approval number is valid until October 22, 2030. The re-registration of this product is approved. Since this product has not been produced for a long time, before resuming production, the holder must complete the relevant work according to the requirements of related documents and submit a resumption application to the municipal drug administration. After on-site inspection and passing the quality check of a batch of products, and subsequent two batches of products passing inspection, it can be marketed and sold

### Related Stocks

- [002907.CN](https://longbridge.com/en/quote/002907.CN.md)

## Related News & Research

- [HKFOODS: Net sales and EBIT rose, but cost inflation and pork export challenges pressured profitability](https://longbridge.com/en/news/294914993.md)
- [A $3.8 Billion Reason Why Procter & Gamble Stock Is in Focus Today](https://longbridge.com/en/news/294987679.md)
- [10:01 ETGreen Science Alliance Developed Carbon Quantum Dot type Pest Repellent from Organic Biomass Waste (Wood Waste, Plant Waste, Food Waste)](https://longbridge.com/en/news/294705147.md)
- [17:29 ETPhysician's Choice 60 Billion Probiotic® Advanced to Launch in 625 Costco Warehouses Nationwide](https://longbridge.com/en/news/294741115.md)
- [Base Power launches large home battery, raises $1B for expansion](https://longbridge.com/en/news/295031756.md)